Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Jinxin Fertility Group Ltd. ( (HK:1951) ) has shared an announcement.
Jinxin Fertility Group Ltd. reported a significant financial downturn for the first half of 2025, with a revenue decrease of 10.7% and a net loss of approximately RMB1,044.1 million, compared to a net profit in the same period of 2024. The company also experienced a substantial decline in non-IFRS adjusted net profit and EBITDA, reflecting challenges in maintaining its financial performance. The board decided against declaring an interim dividend, signaling a cautious approach amid the financial setbacks.
The most recent analyst rating on (HK:1951) stock is a Buy with a HK$4.00 price target. To see the full list of analyst forecasts on Jinxin Fertility Group Ltd. stock, see the HK:1951 Stock Forecast page.
More about Jinxin Fertility Group Ltd.
Jinxin Fertility Group Ltd. is a company incorporated under the laws of the Cayman Islands, operating in the fertility industry. The company focuses on providing fertility services and related healthcare solutions.
Average Trading Volume: 86,206,993
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.84B
See more insights into 1951 stock on TipRanks’ Stock Analysis page.